Top 10 Life Science Startup Investors in Norway in October 2024
A list of 10 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Norway. We rank investors based on the number of investments they made in Life science companies from Norway. We update this investor list every month.Top 10 Life Science Startup Investors in Norway in October 2024
Investor | Life Science Norway investments |
---|---|
Investinor | 2 |
Canica | 1 |
Dynamk Capital | 1 |
Hadean Ventures | 1 |
The Index Project | 1 |
Nordic Impact | 1 |
Project Sandwater | 1 |
SINTEF Venture AS | 1 |
Birk Venture | 1 |
Bakken & Baeck | 1 |
Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.
Show more
Investment focus
- Software, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Norway, United States, Switzerland
Portfolio highlights
- Eyr — Eyr offers digital tools for medical consulting and doctor's prescription regarding various health issues.
- Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
- Ignite — A powerful & easy spend management tool to accelerate your procurement success by bringing clarity, clean data & sophisticated analytics to your fingertips
Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.
Show more
Investment focus
- Beauty, Medical, Biotechnology
- Private Equity, Series A, Series D
- Norway, Denmark, Switzerland
Portfolio highlights
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
- Porterbuddy — They are the gang that delivers to your door the same day you order in the online store.Porterbuddy' is a logistics platform that provides efficient and customer-centric, last-mile delivery of products.
- Galecto — Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medicalneed. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform.
Dynamk Capital is a New York headquartered growth equity and venture capital firm investing in life science industrials: tools, technologies and services that are critical for the discovery, development and production of life-saving therapies. Venture capital for Life Science tools.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Seed, Series B
- United States, Canada, Norway
Portfolio highlights
- CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
- Lucid Scientific — Lucid Scientific is the maker of Resipher - the world's first handheld cell culture monitor to measure real-time oxygen consumption from inside an incubator.
- Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Sweden, Norway, Austria
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Design to improve life is about solving real problems, small and large, simple and complex, systemic and emerging and is a life-long pursuit. The Index Project is a call to action. Are you in?
Show more
Investment focus
- Artificial Intelligence, Chemical, SaaS
- Seed, Series A, Series B
- United States, Denmark, Chile
Nordic Impact invests in, supports, and builds businesses and funds based around technology. The company's goal is to make impact investing mainstream and mobilize all business and capital towards solving the big problems in the world while making great financial returns.
Show more
Investment focus
- Chemical, Life Science, Visual Search
- Seed
- Norway
Portfolio highlights
- Iris.ai — AI for scientific text understanding - Smart search, reading list analysis, auto-generated summaries, data extraction, chatbot with references.
Project Sandwater is a fresh take on venture investments within the Nordics and beyond.
Show more
Investment focus
- Medical, Consulting, Life Science
- Series A
- Norway, The Netherlands
Portfolio highlights
- Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
SINTEF TTO & Venture invest in spin-off companies from SINTEF, NTNU and other research based institutions in Norway. Our dealflow reflect results from state-of-art research and cover a variety of sectors.
SINTEF Venture seek to co-invest with VC funds with sector expertise at an early stage.
Show more
Investment focus
- Manufacturing, Software, Energy
- Seed, Funding Round, Pre-Seed
- Norway, United States, United Kingdom
Portfolio highlights
- Nomono — Introducing Nomono Sound Capsule
- Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
- KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Series A, Funding Round
- Norway, United Kingdom
Portfolio highlights
- APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
- Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
- Accession Therapeutics — Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells. As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour. Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.
A technology-driven design studio. Building digital products, brands and businesses, we help ambitious companies identify, explore and respond to new opportunities.
Show more
Investment focus
- Chemical, Software, Life Science
- Seed, Angel
- Norway
Portfolio highlights
- Versor — Versor develops software necessary for true autonomous drone flight both indoors and outdoors, enabling complete automation of industrial drone operations. They believe this level of automation requires superior localization, which is particularly difficult to achieve indoors and in GPS-denied areas. By removing the need for pilots, entire fleetsof drones may be supervised remotely, enabling true scalability of drone operations across various applications.
- Iris.ai — AI for scientific text understanding - Smart search, reading list analysis, auto-generated summaries, data extraction, chatbot with references.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Social Media
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Medical
Organic Food
Retail
Financial Services
Infrastructure
Platforms
Email
Mobile Advertising
Biotechnology
Hospitality
Fitness
Travel
Recruiting
Cannabis
Art
Wine And Spirits
Medical Device
Crowdfunding
Social
Wellness
Automotive
CleanTech
Music
Transportation
Mobile Apps
Mobile
InsurTech
Enterprise
Franchise
Social Network
Local
Internet
Digital Media
Construction
LGBT
Manufacturing
eSports
Sports
Enterprise Software
Legal
Android
Life Science
Theatre
Film
Sporting Goods
Non Profit
Renewable Energy
SaaS
Software
Restaurants
Social Impact
Celebrity
Facebook
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Morocco
Bahrain
Turkey
Malta
Mali
Serbia
Malaysia
Rwanda
Italy
El Salvador
Venezuela
Peru
Ukraine
Lithuania
Portugal
Myanmar
Lebanon
Sierra Leone
Kuwait
Zimbabwe
Sweden
Cayman Islands
Cambodia
Taiwan
Israel
Panama
Senegal
Mexico
Uruguay
Kazakhstan
Liberia
Jersey
Uganda
Philippines
Tunisia
San Marino
Slovenia
Norway
Zambia
Uzbekistan
Mauritius
Russian Federation
Seychelles
Kenya
Thailand
Liechtenstein
Nicaragua
Puerto Rico
Dominican Republic
Tajikistan
Togo
Poland
Nigeria
Tanzania
Azerbaijan
Namibia
Iceland
United Arab Emirates
Iraq
Bahamas
Luxembourg
Honduras
Bolivia
Isle of Man
Grenada
Albania
Pakistan
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Norway by industry
Clean Energy
Transportation
Financial Services
Cryptocurrency
Big Data
Payments
Medical
Social Network
Medical Device
Social Media
Internet
Manufacturing
Blockchain
Construction
Software
Enterprise Software
Sports
Renewable Energy
Travel
CleanTech
FinTech
EdTech
Biotechnology
Health Care
Consumer
Mobile
Climate
Energy
Proptech
Sustainability
Impact
SaaS
Artificial intelligence
Marketplace
Hardware
Community
Gaming
Retail
Social
Fashion
Web3
B2B
Life Science
Education
Publishing
Oil and Gas
Music
Enterprise
Biotech
Food and Beverage
Real Estate
Digital Media
Agriculture (agtech)
Media (entertainment)
Video Games